within Pharmacolibrary.Drugs.ATC.J;

model J05AB06_1
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 6.333333333333333e-05,
    adminDuration  = 600,
    adminMass      = 350 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.00067,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.00063,
    k12             = 0.07,
    k21             = 0.07
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>J05AB06_1</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Ganciclovir is an antiviral medication used for the treatment and prevention of cytomegalovirus (CMV) infections in immunocompromised individuals. It remains an essential antiviral for this indication.</p><h4>Pharmacokinetics</h4><p>Population pharmacokinetics model in renal transplant recipients; intravenous administration of 5 mg/kg.</p><h4>References</h4><ol><li><p>Corum, O, et al., &amp; Elmas, M (2022). Effect of ketoprofen on intravenous pharmacokinetics of ganciclovir in chukar partridges (Alectoris chukar). <i>Journal of veterinary pharmacology and therapeutics</i> 45(1) 126–132. DOI:<a href=\"https://doi.org/10.1111/jvp.13027\">10.1111/jvp.13027</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/34719792/\">https://pubmed.ncbi.nlm.nih.gov/34719792</a></p></li><li><p>Nguyen, T, et al., &amp; Hirt, D (2021). Population Pharmacokinetics of Intravenous Ganciclovir and Oral Valganciclovir in a Pediatric Population To Optimize Dosing Regimens. <i>Antimicrobial agents and chemotherapy</i> 65(3) –. DOI:<a href=\"https://doi.org/10.1128/AAC.02254-20\">10.1128/AAC.02254-20</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/33318012/\">https://pubmed.ncbi.nlm.nih.gov/33318012</a></p></li><li><p>Okumura, N, et al., &amp; Koizumi, N (2019). Stability, safety, and pharmacokinetics of ganciclovir eye drops prepared from ganciclovir for intravenous infusion. <i>Japanese journal of ophthalmology</i> 63(3) 289–296. DOI:<a href=\"https://doi.org/10.1007/s10384-019-00665-8\">10.1007/s10384-019-00665-8</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/30941593/\">https://pubmed.ncbi.nlm.nih.gov/30941593</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end J05AB06_1;
